9241.5000 131.00 (1.44%)
NSE Jul 11, 2025 15:31 PM
Volume: 20,847
 

9241.50
1.44%
Serum Institute may conduct more tests to get half-dose efficacy
Moneycontrol
Preliminary results on the AstraZeneca vaccine were based on a total of 131 COVID-19 cases in a study involving 11,636 participants.
More from AstraZeneca Pharma India Ltd.
Recommended